| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Unit of Molecular Genetics, the 3 Institute of Pathology, and the 6 Division of Medical Genetics, University of Lausanne, Switzerland; the 2 Department of Ophthalmology, Hôpital Jules Gonin, University of Lausanne, Switzerland; the 4 Department of Ophthalmology, Vanderbilt University, Nashville, Tennessee; and the 5 Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Abstract
PURPOSE. Recently, the authors identified a gene, BIGH3, in which different mutations cause a group of hereditary corneal dystrophies: lattice type I and IIIA (CDLI and CDLIIIA), granular Groenouw type I (CDGGI), Avellino (CDA), and Reis–Bücklers’ (CDRB). All these disorders are characterized by the progressive accumulation of corneal deposits with different structural organization. Experiments were conducted to determine the role of kerato-epithelin (KE), the product of BIGH3, in the pathogenesis of the diseases.
METHODS. KE-15 and KE-2, two rabbit antisera raised against peptides from the 69–364 and 426–682 amino acid regions of KE respectively, were used for immunohistology of the corneas obtained after keratoplasty in six CDLI patients, three CDGGI patients, and one CDA patient.
RESULTS. The nonamyloid deposits observed in CDGGI stained intensively with KE-15 and KE-2, whereas the amyloid deposits in all analyzed CDLI corneas reacted to KE-2 but not to KE-15. In the CDA cornea, where amyloid and nonamyloid inclusions were present, positive staining with both antisera was observed.
CONCLUSIONS. Pathologic amyloid and nonamyloid deposits observed in CDLI, CDGGI-, and CDA-affected corneas are caused by KE accumulation. Different staining patterns of amyloid and nonamyloid deposits observed with antibodies against the amino and carboxyl termini of KE suggest that two mechanisms of KE misfolding are implicated in the pathogenesis of 5q31-linked corneal dystrophies.
This article has been cited by other articles:
|
|
 |
|
  C Gruenauer-Kloevekorn, I Clausen, E Weidle, M Wolter-Roessler, F Tost, H E Volcker, D P Schulze, W Heinritz, T Reinhard, U Froster, et al. TGFBI (BIGH3) gene mutations in German families: two novel mutations associated with unique clinical and histopathological findings Br. J. Ophthalmol., July 1, 2009; 93(7): 932 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. V. Jurkunas, M. Bitar, and I. Rawe Colocalization of Increased Transforming Growth Factor-{beta}-Induced Protein (TGFBIp) and Clusterin in Fuchs Endothelial Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Aldave, V. S. Yellore, B. Sonmez, N. Bourla, A. K. Salem, M. A. Khan, S. A. Rayner, and B. J. Glasgow A Novel Variant of Combined Granular-Lattice Corneal Dystrophy Associated With the Met619Lys Mutation in the TGFBI Gene Arch Ophthalmol, March 1, 2008; 126(3): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Becker, B. Erdlenbruch, I. Noskova, A. Schramm, M. Aumailley, D. F. Schorderet, and L. Schweigerer Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res., May 15, 2006; 66(10): 5314 - 5321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kannabiran, M. S. Sridhar, S. K. Chakravarthi, G. K. Vemuganti, and M. Lakshmipathi Genotype-Phenotype Correlation in 2 Indian Families With Severe Granular Corneal Dystrophy Arch Ophthalmol, August 1, 2005; 123(8): 1127 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stix, M. Leber, P. Bingemer, C. Gross, J. Ruschoff, M. Fandrich, D. F. Schorderet, C. K. Vorwerk, M. Zacharias, A. Roessner, et al. Hereditary Lattice Corneal Dystrophy Is Associated with Corneal Amyloid Deposits Enclosing C-Terminal Fragments of Keratoepithelin Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morand, V. Buchillier, F. Maurer, C. Bonny, Y. Arsenijevic, F. L. Munier, and D. F. Schorderet Induction of Apoptosis in Human Corneal and HeLa Cells by Mutated BIGH3 Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2973 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-E. Kim, R.-W. Park, J.-Y. Choi, Y.-C. Bae, K.-S. Kim, C.-K. Joo, and I.-S. Kim Molecular Properties of Wild-Type and Mutant {beta}IG-H3 Proteins Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 656 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jun, S. H. Liu, E. H. Koo, D. V. Do, W. J. Stark, and J. D. Gottsch Microarray Analysis of Gene Expression in Human Donor Corneas Arch Ophthalmol, November 1, 2001; 119(11): 1629 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. A. Ridgway, S. Akhtar, F. L. Munier, D. F. Schorderet, H. Stewart, R. Perveen, R. E. Bonshek, M. T. P. Odenthal, M. Dixon, R. Barraquer, et al. Ultrastructural and Molecular Analysis of Bowman's Layer Corneal Dystrophies: An Epithelial Origin? Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3286 - 3292. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Korvatska, H. Henry, Y. Mashima, M. Yamada, C. Bachmann, F. L. Munier, and D. F. Schorderet Amyloid and Non-amyloid Forms of 5q31-linked Corneal Dystrophy Resulting from Kerato-epithelin Mutations at Arg-124 Are Associated with Abnormal Turnover of the Protein J. Biol. Chem., April 6, 2000; 275(15): 11465 - 11469. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
